138 related articles for article (PubMed ID: 22865267)
1. Memory T cells are uniquely resistant to melanoma-induced suppression.
Wentworth L; Meyers JV; Alam S; Russ AJ; Suresh M; Cho CS
Cancer Immunol Immunother; 2013 Jan; 62(1):149-59. PubMed ID: 22865267
[TBL] [Abstract][Full Text] [Related]
2. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
3. Suppression of T-cell expansion by melanoma is exerted on resting cells.
Russ AJ; Wentworth L; Xu K; Rakhmilevich A; Seroogy CM; Sondel PM; Suresh M; Cho CS
Ann Surg Oncol; 2011 Dec; 18(13):3848-57. PubMed ID: 21465311
[TBL] [Abstract][Full Text] [Related]
4. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
[TBL] [Abstract][Full Text] [Related]
5. Melanoma-induced suppression of tumor antigen-specific T cell expansion is comparable to suppression of global T cell expansion.
Russ AJ; Xu K; Wentworth L; Alam S; Meyers JV; Macklin MD; Rakhmilevich AL; Rajamanickam V; Suresh M; Cho CS
Cell Immunol; 2011; 271(1):104-9. PubMed ID: 21741629
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
8. Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts.
Zimmerman C; Brduscha-Riem K; Blaser C; Zinkernagel RM; Pircher H
J Exp Med; 1996 Apr; 183(4):1367-75. PubMed ID: 8666895
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by
Abu Eid R; Ahmad S; Lin Y; Webb M; Berrong Z; Shrimali R; Kumai T; Ananth S; Rodriguez PC; Celis E; Janik J; Mkrtichyan M; Khleif SN
Cancer Res; 2017 Aug; 77(15):4135-4145. PubMed ID: 28615225
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo.
Grayson JM; Harrington LE; Lanier JG; Wherry EJ; Ahmed R
J Immunol; 2002 Oct; 169(7):3760-70. PubMed ID: 12244170
[TBL] [Abstract][Full Text] [Related]
13. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
[TBL] [Abstract][Full Text] [Related]
14. CD8 T cell memory in B cell-deficient mice.
Asano MS; Ahmed R
J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
[TBL] [Abstract][Full Text] [Related]
15. Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think.
McDermott DS; Varga SM
J Immunol; 2011 Dec; 187(11):5568-76. PubMed ID: 22043009
[TBL] [Abstract][Full Text] [Related]
16. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
[TBL] [Abstract][Full Text] [Related]
17. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.
Whitmire JK; Murali-Krishna K; Altman J; Ahmed R
Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):373-9. PubMed ID: 10794058
[TBL] [Abstract][Full Text] [Related]
18. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice.
Homann D; Tishon A; Berger DP; Weigle WO; von Herrath MG; Oldstone MB
J Virol; 1998 Nov; 72(11):9208-16. PubMed ID: 9765468
[TBL] [Abstract][Full Text] [Related]
20. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.
Klebanoff CA; Gattinoni L; Palmer DC; Muranski P; Ji Y; Hinrichs CS; Borman ZA; Kerkar SP; Scott CD; Finkelstein SE; Rosenberg SA; Restifo NP
Clin Cancer Res; 2011 Aug; 17(16):5343-52. PubMed ID: 21737507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
